Literature DB >> 16133996

Deficiency of somatic hypermutation of immunoglobulin G transcripts is a better predictor of severe respiratory tract infections than lack of memory B cells in common variable immunodeficiency.

Lone Schejbel1, Hanne Marquart, Vagn Andersen, Henrik Permin, Pernille Andersen, Arne Svejgaard, Torben Barington.   

Abstract

Defects of memory B cells and of somatic hypermutation (SHM) are involved in the pathogenesis of common variable immunodeficiency (CVID). Here we report for the first time a systematic study of the relationship between memory B cell deficiency and SHM abnormalities in CVID, and relate these variables to prediagnostic infections. Isotype switched Vh3-23 transcripts were undetectable or low in 30% (IgG) and 63% (IgA) of the patients, but never in controls (P < 0.001). When measurable, the SHM fraction of transcripts was significantly lower in patients (IgM: median 32% vs. 56% (P = 0.0002); IgG: 72% vs. 87% (P = 0.0002); IgA: 81% vs. 88% (P = 0.04)). The concentration of switched (CD19+/CD27+/IgG+) and unswitched (CD19+/CD27+/IgM+/IgD+) memory cells was reduced in 75% and 58% of the patients, respectively. Patients with reduced concentrations of switched memory B cells had normal or low SHM, and only the IgG SHM fraction correlated with prediagnostic incidence of severe respiratory tract infections (P = 0.004).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133996     DOI: 10.1007/s10875-005-5034-x

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  51 in total

1.  Delineation of selective influences shaping the mutated expressed human Ig heavy chain repertoire.

Authors:  T Dörner; H P Brezinschek; S J Foster; R I Brezinschek; N L Farner; P E Lipsky
Journal:  J Immunol       Date:  1998-03-15       Impact factor: 5.422

2.  Identification of a subset of common variable immunodeficiency patients with impaired B-cell protein tyrosine phosphorylation.

Authors:  R Schwartz; Y B Porat; Z Handzel; Z Sthoeger; B Z Garty; R Confino-Cohen; J Levy; I Zan-Bar
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

Review 3.  Common variable immunodeficiency.

Authors:  M C Sneller
Journal:  Am J Med Sci       Date:  2001-01       Impact factor: 2.378

4.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).

Authors:  M E Conley; L D Notarangelo; A Etzioni
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

Review 5.  Common variable immunodeficiency.

Authors:  C Cunningham-Rundles
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

6.  Bias in somatic hypermutation of human VH genes.

Authors:  R A Insel; W S Varade
Journal:  Int Immunol       Date:  1994-09       Impact factor: 4.823

7.  Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects.

Authors:  B Piqueras; C Lavenu-Bombled; L Galicier; F Bergeron-van der Cruyssen; L Mouthon; S Chevret; P Debré; C Schmitt; E Oksenhendler
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

8.  Defective CD2 T cell pathway activation in common variable immunodeficiency (CVID).

Authors:  S Zielen; T J Dengler; P Bauscher; S C Meuer
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

9.  Reduced interleukin-2 (IL-2) production in common variable immunodeficiency is due to a primary abnormality of CD4+ T cell differentiation.

Authors:  E M Eisenstein; J S Jaffe; W Strober
Journal:  J Clin Immunol       Date:  1993-07       Impact factor: 8.317

10.  Defective surface expression of attractin on T cells in patients with common variable immunodeficiency (CVID).

Authors:  N Pozzi; L Gaetaniello; B Martire; D De Mattia; B Balestrieri; E Cosentini; S F Schlossman; J S Duke-Cohan; C Pignata
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

View more
  9 in total

1.  Role of B cells in common variable immune deficiency.

Authors:  Sam Ahn; Charlotte Cunningham-Rundles
Journal:  Expert Rev Clin Immunol       Date:  2009-09       Impact factor: 4.473

2.  Long-term follow-up on affinity maturation and memory B-cell generation in patients with common variable immunodeficiency.

Authors:  V Ballegaard; H Permin; T L Katzenstein; H V Marquart; L Schejbel
Journal:  J Clin Immunol       Date:  2013-05-07       Impact factor: 8.317

Review 3.  New frontiers of primary antibody deficiencies.

Authors:  Mirjam van der Burg; Menno C van Zelm; Gertjan J A Driessen; Jacques J M van Dongen
Journal:  Cell Mol Life Sci       Date:  2011-11-01       Impact factor: 9.261

4.  Altered spectrum of somatic hypermutation in common variable immunodeficiency disease characteristic of defective repair of mutations.

Authors:  Bhargavi Duvvuri; Venkata R S K Duvvuri; Jörg Grigull; Alberto Martin; Qiang Pan-Hammarström; Gillian E Wu; Mani Larijani
Journal:  Immunogenetics       Date:  2010-10-12       Impact factor: 2.846

5.  Memory B cells in common variable immunodeficiency: clinical associations and sex differences.

Authors:  Silvia Sánchez-Ramón; Lin Radigan; Joyce E Yu; Susan Bard; Charlotte Cunningham-Rundles
Journal:  Clin Immunol       Date:  2008-07-11       Impact factor: 3.969

Review 6.  Somatic Hypermutation Defects in Common Variable Immune Deficiency.

Authors:  María Belén Almejun; Mercedes Borge
Journal:  Curr Allergy Asthma Rep       Date:  2017-10-05       Impact factor: 4.806

Review 7.  Genetic defects in common variable immunodeficiency.

Authors:  O Kopecký; S Lukesová
Journal:  Int J Immunogenet       Date:  2007-08       Impact factor: 1.466

8.  Expression of activation-induced cytidine deaminase gene in B lymphocytes of patients with common variable immunodeficiency.

Authors:  Hassan Abolhassani; Amir Salek Farrokhi; Shabnam Pourhamdi; Payam Mohammadinejad; Bamdad Sadeghi; Seyed-Mohammad Moazzeni; Asghar Aghamohammadi
Journal:  Iran J Pediatr       Date:  2013-08       Impact factor: 0.364

9.  Evidence of perturbed germinal center dynamics, but preserved antibody diversity, in end-stage renal disease.

Authors:  Kristian Assing; Christian Nielsen; Marianne Jakobsen; Alexandra Scholze; Mads Nybo; Grete Soerensen; Sussie Mortensen; Knud Vejen; Torben Barington; Claus Bistrup
Journal:  Immun Inflamm Dis       Date:  2016-05-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.